Supernus Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US8684591089

SecuritySUPN / Supernus Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,493,446 shares
Latest Disclosed Value $ 77,196,223
Citadel Advisors Llc ownership in SUPN / Supernus Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,493,446 shares of Supernus Pharmaceuticals, Inc. (US:SUPN) valued at $77,196,224 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 452,959 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of 229.71% during the quarter. The current value of the position is $66,831,708 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (SUPN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 34,600 of underlying shares valued at $1,788,474 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SUPN / Supernus Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,493,446 1,040,487 229.71 77,196 242.91 0.0110
2026-02-17 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 452,959 -963,967 -68.03 22,512 -66.75 0.0030
2025-11-14 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,416,926 1,241,792 709.05 67,715 1,126.70 0.0103
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 175,134 13,620 8.43 5,520 4.37 0.0010
2025-05-15 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 161,514 67,074 71.02 5,290 54.92 0.0010
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 94,440 -9,812 -9.41 3,415 5.05 0.0006
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 104,252 -38,680 -27.06 3,251 -14.99 0.0006
2024-08-14 2024-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 142,932 55,638 63.74 3,823 28.42 0.0008
2024-05-15 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 87,294 -122,827 -58.46 2,978 -51.04 0.0006
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 210,121 -165,705 -44.09 6,081 -41.32 0.0012
2023-11-14 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 375,826 286,839 322.34 10,362 287.47 0.0022
2023-08-14 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 88,987 -15,167 -14.56 2,675 -29.13 0.0006
2023-05-15 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 104,154 -289,681 -73.55 3,773 -73.14 0.0008
2023-02-14 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 393,835 84,144 27.17 14,048 34.01 0.0033
2022-11-14 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 309,691 216,771 233.29 10,483 290.14 0.0024
2022-08-15 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 92,920 -13,341 -12.55 2,687 -21.75 0.0007
2022-05-16 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 106,261 -854 -0.80 3,434 9.92 0.0007
2022-02-14 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 107,115 91,880 603.09 3,124 669.46 0.0006
2021-11-15 2021-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 15,235 -389,288 -96.23 406 -96.74 0.0001
2021-08-16 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 404,523 352,367 675.60 12,456 812.53 0.0028
2021-05-21 2021-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 52,156 37,080 245.95 1,365 260.16 0.0003
2021-05-17 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 52,156 37,080 1,365 0.0003
2021-02-16 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 15,076 15,076 379 0.0001
2020-08-14 2020-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 0 -713,240 -100.00 0 -100.00
2020-05-15 2020-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 713,240 432,084 153.68 12,832 92.41 0.0058
2020-02-14 2019-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 281,156 52,236 22.82 6,669 6.03 0.0029
2019-11-14 2019-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 228,920 94,365 70.13 6,290 41.28 0.0030
2019-08-14 2019-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 134,555 -12,083 -8.24 4,452 -13.37 0.0020
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 146,638 71,646 95.54 5,139 106.30 0.0026
2019-02-14 2018-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 74,992 29,128 63.51 2,491 7.88 0.0014
2018-11-13 2018-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 45,864 -29,610 -39.23 2,309 -48.88 0.0010
2018-08-14 2018-06-30 13F/A-1 SUPERNUS PHARMACEUTICALS Cmn 868459108 75,474 -138,170 -64.67 4,517 -53.84 0.0022
2018-08-10 2018-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 75,474 -138,170 4,517
2018-05-14 2018-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS Cmn 868459108 213,644 201,204 1,617.40 9,785 1,872.78 0.0054
2018-05-11 2018-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 213,644 201,204 9,785
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 12,440 -61,463 -83.17 496 -83.22 0.0003
2017-11-09 2017-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 73,903 29,112 65.00 2,956 53.16 0.0023
2017-08-11 2017-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 44,791 44,791 1,930 0.0016
2017-05-12 2017-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 0 -40,122 -100.00 0 -100.00
2017-02-10 2016-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 40,122 40,122 1,013 0.0010
2016-08-12 2016-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 0 -39,112 -100.00 0 -100.00
2017-01-31 2016-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS Cmn 868459108 39,112 -276,899 -87.62 596 -85.97 0.0008
2016-05-13 2016-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 39,112 596
2017-01-31 2015-12-31 13F/A-1 SUPERNUS PHARMACEUTICALS Cmn 868459108 316,011 300,161 1,893.76 4,247 1,813.06 0.0046
2016-02-12 2015-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 316,011 4,247
2015-11-16 2015-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 15,850 -143,114 -90.03 222 -91.77 0.0002
2015-08-14 2015-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 158,964 -31,440 -16.51 2,699 17.25 0.0024
2015-05-15 2015-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 190,404 -73,312 -27.80 2,302 5.16 0.0026
2015-02-17 2014-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 263,716 68,770 35.28 2,189 29.22 0.0026
2014-11-14 2014-09-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 194,946 161,147 476.78 1,694 357.84 0.0021
2014-08-14 2014-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 33,799 -46,127 -57.71 370 -48.25 0.0005
2014-05-15 2014-03-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 79,926 64,997 435.37 715 532.74 0.0010
2014-02-14 2013-12-31 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 14,929 6,564 78.47 113 109.26 0.0001
2013-08-14 2013-06-30 13F SUPERNUS PHARMACEUTICALS Cmn 868459108 8,365 8,365 54 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 9,300 -18.42 444 23.68 n/a n/a n/a
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 11,400 29.55 359 24.65 n/a n/a n/a
2025-05-15 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 8,800 -27.27 288 -34.10 n/a n/a n/a
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 12,100 -19.33 438 -6.42 n/a n/a n/a
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 15,000 41.51 468 65.02 n/a n/a n/a
2024-08-14 2024-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 10,600 27.71 284 0.00 n/a n/a n/a
2024-05-15 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 8,300 9.21 283 29.22 n/a n/a n/a
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 7,600 28.81 220 35.19 n/a n/a n/a
2023-11-14 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 5,900 -41.00 163 -46.00 n/a n/a n/a
2023-08-14 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 10,000 51.52 301 25.52 n/a n/a n/a
2023-05-15 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 6,600 -13.16 239 -11.81 n/a n/a n/a
2023-02-14 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 7,600 271 n/a n/a n/a
2022-11-14 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 12,100 -17.12 350 -25.85 n/a n/a n/a
2022-05-16 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 14,600 -59.67 472 -55.30 n/a n/a n/a
2022-02-14 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 36,200 61.61 1,056 76.88 n/a n/a n/a
2021-11-15 2021-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 22,400 -17.65 597 -28.67 n/a n/a n/a
2021-08-16 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 27,200 -11.40 837 4.10 n/a n/a n/a
2021-05-21 2021-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Call 30,700 113.19 804 122.10 n/a n/a n/a
2021-05-17 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 30,700 804 n/a n/a n/a
2021-02-16 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 14,400 362 n/a n/a n/a
2020-11-16 2020-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 30,100 33.19 715 75.68 n/a n/a n/a
2020-05-15 2020-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 22,600 407 n/a n/a n/a
2020-02-14 2019-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 25,300 123.89 695 85.83 n/a n/a n/a
2019-08-14 2019-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 11,300 -39.25 374 -42.64 n/a n/a n/a
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 18,600 20.78 652 27.34 n/a n/a n/a
2019-02-14 2018-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 15,400 -37.65 512 -58.84 n/a n/a n/a
2018-11-13 2018-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 24,700 114.78 1,244 80.81 n/a n/a n/a
2018-08-14 2018-06-30 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 11,500 -43.90 688 -26.73 n/a n/a n/a
2018-08-10 2018-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 11,500 688 n/a n/a n/a
2018-05-14 2018-03-31 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 20,500 0.99 939 16.07 n/a n/a n/a
2018-05-11 2018-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 20,500 939 n/a n/a n/a
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 20,300 -24.25 809 -24.53 n/a n/a n/a
2017-11-09 2017-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 26,800 41.80 1,072 31.53 n/a n/a n/a
2017-08-11 2017-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 18,900 -22.86 815 6.26 n/a n/a n/a
2017-05-12 2017-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 24,500 105.88 767 155.67 n/a n/a n/a
2017-02-10 2016-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 11,900 9.17 300 11.11 n/a n/a n/a
2017-01-31 2016-09-30 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 10,900 -25.34 270 -9.09 n/a n/a n/a
2016-11-10 2016-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 10,900 270 n/a n/a n/a
2017-01-31 2016-06-30 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 14,600 -19.78 297 6.83 n/a n/a n/a
2016-08-12 2016-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 14,600 297 n/a n/a n/a
2017-01-31 2016-03-31 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 18,200 219.30 278 261.04 n/a n/a n/a
2016-05-13 2016-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 18,200 278 n/a n/a n/a
2017-01-31 2015-12-31 13F/A SUPERNUS PHARMACEUTICALS Cmn Call 5,700 -38.71 77 -40.77 n/a n/a n/a
2016-02-12 2015-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 5,700 77 n/a n/a n/a
2015-11-16 2015-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 9,300 -6.06 130 -22.62 n/a n/a n/a
2015-08-14 2015-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 9,900 -35.29 168 -9.19 n/a n/a n/a
2015-05-15 2015-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 15,300 325.00 185 516.67 n/a n/a n/a
2015-02-17 2014-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 3,600 -57.65 30 -59.46 n/a n/a n/a
2014-11-14 2014-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 8,500 226.92 74 164.29 n/a n/a n/a
2014-08-14 2014-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 2,600 -43.48 28 -31.71 n/a n/a n/a
2014-05-15 2014-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 4,600 76.92 41 105.00 n/a n/a n/a
2014-02-14 2013-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Call 2,600 -95.50 20 -95.28 n/a n/a n/a
2013-11-14 2013-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 57,800 -33.02 424 -23.60 n/a n/a n/a
2013-08-14 2013-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Call 86,300 555 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 34,600 33.59 1,788 38.93 n/a n/a n/a
2026-02-17 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 25,900 1,287 n/a n/a n/a
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 6,300 5.00 206 -4.63 n/a n/a n/a
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 6,000 130.77 217 166.67 n/a n/a n/a
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 2,600 -50.00 81 -41.73 n/a n/a n/a
2024-08-14 2024-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 5,200 -45.26 139 -57.10 n/a n/a n/a
2024-05-15 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 9,500 -34.93 324 -23.22 n/a n/a n/a
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 14,600 668.42 423 711.54 n/a n/a n/a
2023-11-14 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 1,900 -20.83 52 -27.78 n/a n/a n/a
2023-08-14 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 2,400 140.00 72 100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 1,000 400.00 36 414.29 n/a n/a n/a
2023-02-14 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 200 7 n/a n/a n/a
2022-08-15 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 10,400 -25.71 336 -17.65 n/a n/a n/a
2022-02-14 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 14,000 41.41 408 54.55 n/a n/a n/a
2021-11-15 2021-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 9,900 -67.00 264 -71.43 n/a n/a n/a
2021-08-16 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 30,000 49.25 924 75.67 n/a n/a n/a
2021-05-21 2021-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Put 20,100 -12.23 526 -8.68 n/a n/a n/a
2021-05-17 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 20,100 526 n/a n/a n/a
2021-02-16 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 22,900 -24.92 576 -9.43 n/a n/a n/a
2020-11-16 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 30,500 636 n/a n/a n/a
2020-05-15 2020-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 14,300 12.60 339 -2.87 n/a n/a n/a
2019-11-14 2019-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 12,700 -40.93 349 -50.91 n/a n/a n/a
2019-08-14 2019-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 21,500 -39.27 711 -42.66 n/a n/a n/a
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 35,400 115.85 1,240 127.52 n/a n/a n/a
2019-02-14 2018-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 16,400 -57.95 545 -72.25 n/a n/a n/a
2018-11-13 2018-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 39,000 22.64 1,964 3.21 n/a n/a n/a
2018-08-14 2018-06-30 13F/A SUPERNUS PHARMACEUTICALS Cmn Put 31,800 139.10 1,903 212.48 n/a n/a n/a
2018-08-10 2018-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 31,800 1,903 n/a n/a n/a
2018-05-14 2018-03-31 13F/A SUPERNUS PHARMACEUTICALS Cmn Put 13,300 -33.83 609 -23.97 n/a n/a n/a
2018-05-11 2018-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 13,300 609 n/a n/a n/a
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 20,100 -17.62 801 -17.93 n/a n/a n/a
2017-11-09 2017-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 24,400 275.38 976 248.57 n/a n/a n/a
2017-08-11 2017-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 6,500 -53.90 280 -36.51 n/a n/a n/a
2017-05-12 2017-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 14,100 45.36 441 80.00 n/a n/a n/a
2017-02-10 2016-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 9,700 7.78 245 9.87 n/a n/a n/a
2017-01-31 2016-09-30 13F/A SUPERNUS PHARMACEUTICALS Cmn Put 9,000 223 n/a n/a n/a
2016-11-10 2016-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 9,000 223 n/a n/a n/a
2016-05-13 2016-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A SUPERNUS PHARMACEUTICALS Cmn Put 19,600 -15.52 263 -19.08 n/a n/a n/a
2016-02-12 2015-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 19,600 263 n/a n/a n/a
2015-11-16 2015-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 23,200 68.12 325 38.89 n/a n/a n/a
2015-08-14 2015-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 13,800 81.58 234 154.35 n/a n/a n/a
2015-05-15 2015-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 7,600 -33.91 92 -3.16 n/a n/a n/a
2015-02-17 2014-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 11,500 -0.86 95 -5.94 n/a n/a n/a
2014-11-14 2014-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 11,600 -60.27 101 -68.44 n/a n/a n/a
2014-08-14 2014-06-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 29,200 -42.63 320 -29.67 n/a n/a n/a
2014-05-15 2014-03-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 50,900 147.09 455 193.55 n/a n/a n/a
2014-02-14 2013-12-31 13F SUPERNUS PHARMACEUTICALS Cmn Put 20,600 1,187.50 155 1,191.67 n/a n/a n/a
2013-11-14 2013-09-30 13F SUPERNUS PHARMACEUTICALS Cmn Put 1,600 12 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.